Austria to India: Kit Import Trade Route

The Austria to India Kit corridor is one of India's established pharmaceutical import routes from Austria, with 242 shipments documented worth a combined $60.0M USD. The route is dominated by QIAGEN SCIENCES LLC , which alone accounts for roughly 88% of all import value, reflecting the consolidated nature of Austria's kit export sector.

Across 17 active Austria suppliers, the average shipment value stands at $247.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 33.8%, placing it at rank #14 among India's top kit import origins globally.

On the Indian buyer side, key Indian importers include QIAGEN INDIA PRIVATE LIMITED , BAXTER INDIA PRIVATE LIMITED, BAXTER INDIA PRIVATE LIMITED and 6 others. QIAGEN INDIA PRIVATE LIMITED is the single largest Indian importer with 2 shipments valued at $52.6M USD.

India's kit imports from Austria are driven primarily by a handful of large-scale Austria manufacturers. QIAGEN SCIENCES LLC with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — Indian buyers benefit from Austria supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — QIAGEN SCIENCES LLC , BAXTER HEALTHCARE SA, BAXTER HEALTHCARE SA — together account for 100% of total trade value on this route. The average shipment value of $247.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tisseel kit vhsd sa 2ml india sterile absorbable haemostat for control of surgical vessel bleeding list 4 sr no.92 61 and tisseel kit vhsd sa 2ml india sterile absorbable haemostat for control of surgical vessel bleeding list 4 sr no.92 55, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Austria supplier.

On the buying side, QIAGEN INDIA PRIVATE LIMITED is the largest importer with 2 shipments worth $52.6M USD — representing 88% of all kit imports from Austria on this route. A total of 9 buyers are active on this corridor.